BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Orexigen Therapeutics, Inc. Presents New Data Showing Contrave(R) Significantly Lowers Weight, Improves Blood Glucose Control in Obese Patients With Type 2 Diabetes

  June 28, 2010

   · 

  7 min read
• Drug Development

  New Bristol-Myers Squibb Company, AstraZeneca PLC Diabetes Drug, Dapagliflozin Effective in Study

  June 28, 2010

   · 

  9 min read
• Drug Development

  Amylin Pharmaceuticals, Inc.: Type 2 Diabetes Patients With Long-Standing Disease Achieved Glycemic Control When BYETTA(R) Was Added to Lantus(R)

  June 28, 2010

   · 

  9 min read
• Drug Development

  Biodel Inc.: Final Results of Phase 3 Study of VIAject(R) vs. Regular Human Insulin in Patients with Type 2 Diabetes Presented at American Diabetes Association Annual Meeting

  June 28, 2010

   · 

  6 min read
• Drug Development

  New Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Diabetes Drug, Canagliflozin Effective in Mid-Stage Study

  June 28, 2010

   · 

  5 min read
• Pharm Country

  Cancer Vaccine Maker Dendreon Corporation Can’t Meet Demand

  June 28, 2010

   · 

  1 min read
• Business

  Rivertop Renewables Announces James Stoppert as Chief Executive Officer

  June 28, 2010

   · 

  3 min read
• Drug Development

  Amylin Pharmaceuticals, Inc.: BYDUREON(TM) Safety and Tolerability Pooled Summary Data Presented at American Diabetes Association 2010

  June 28, 2010

   · 

  11 min read
• FDA

  Masimo Corporation Receives FDA Clearance for Pronto-7 Making the Revolutionary Palm-sized Device for Noninvasive Hemoglobin Spot-Check Testing Available to U.S. Healthcare Providers

  June 28, 2010

   · 

  7 min read
• Business

  Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT)

  June 28, 2010

   · 

  1 min read